ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89 | -15.2% | 28,284 | +33.6% | 0.00% | 0.0% |
| Q2 2023 | $105 | +18.0% | 21,175 | +16.9% | 0.00% | 0.0% |
| Q1 2023 | $89 | +7.2% | 18,110 | +37.0% | 0.00% | 0.0% |
| Q4 2022 | $83 | -100.0% | 13,220 | -23.5% | 0.00% | -60.0% |
| Q3 2022 | $186,000 | +195.2% | 17,272 | +211.8% | 0.01% | +150.0% |
| Q2 2022 | $63,000 | -4.5% | 5,540 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $66,000 | -20.5% | 7,276 | +123.5% | 0.00% | 0.0% |
| Q3 2021 | $83,000 | 0.0% | 3,255 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $83,000 | -25.9% | 3,220 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $112,000 | +38.3% | 3,180 | -1.9% | 0.00% | 0.0% |
| Q4 2020 | $81,000 | +84.1% | 3,240 | +172.7% | 0.00% | 0.0% |
| Q3 2020 | $44,000 | – | 1,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |